Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Chelsea Therapeutics: Likely to Double on Safe, Proven Asset
Chelsea Therapeutics: Likely to Double on Safe, Proven Asset
Chelsea Therapeutics: Likely to Double on Safe, Proven Asset
Submitted by
admin
on July 30, 2011 - 9:55am
Source:
Seeking Alpha
News Tags:
Chelsea Therapeutics
Droxidopa
CH-4051
Headline:
Chelsea Therapeutics: Likely to Double on Safe, Proven Asset
Do Not Allow Advertisers to Use My Personal information
